Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Ristori

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
JAMA Neurology|May 12, 2015
Association between vaccines and neuroinflammation: time, risks, and benefitsGiovanni Ristori, Rosella Mechelli, Marco Salvetti
Experimental Neurology|December 11, 2012
The mood-immunity relationship in multiple sclerosisGiovanni Ristori, Viviana Annibali, Marco Salvetti
Current Opinion in Immunology|November 18, 2018
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosisGiovanni Ristori, Denise Faustman, Giuseppe Matarese, et al.
The Lancet. Neurology|June 16, 2016
Riluzole in patients with hereditary cerebellar ataxia - Authors' replySilvia Romano, Giulia Coarelli, Nicola Vanacore, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 6, 2015
Subacute multicranial neuropathy revealing an early case of meningeal syphilisBarbara Casolla, Giovanni Ristori, Andrea Romano, et al.
Neurology|August 27, 2014
Author responseGiovanni Ristori, Silvia Romano, Giulia Coarelli, et al.
Neurology|September 4, 2014
Author responseGiovanni Ristori, Silvia Romano, Giulia Coarelli, et al.
Expert Review of Clinical Immunology|May 6, 2010
Multiple sclerosis etiology: beyond genes and environmentRosella Mechelli, Viviana Annibali, Giovanni Ristori, et al.
Frontiers in Immunology|June 19, 2023
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature reviewGianmarco Bellucci, Angela Albanese, Caterina Rizzi, et al.
Current Medicinal Chemistry|January 26, 2019
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of EdaravoneCristina Agresti, Rosella Mechelli, Stefania Olla, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
JAMA Neurology|May 12, 2015
Association between vaccines and neuroinflammation: time, risks, and benefitsGiovanni Ristori, Rosella Mechelli, Marco Salvetti
Experimental Neurology|December 11, 2012
The mood-immunity relationship in multiple sclerosisGiovanni Ristori, Viviana Annibali, Marco Salvetti
Current Opinion in Immunology|November 18, 2018
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosisGiovanni Ristori, Denise Faustman, Giuseppe Matarese, et al.
The Lancet. Neurology|June 16, 2016
Riluzole in patients with hereditary cerebellar ataxia - Authors' replySilvia Romano, Giulia Coarelli, Nicola Vanacore, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 6, 2015
Subacute multicranial neuropathy revealing an early case of meningeal syphilisBarbara Casolla, Giovanni Ristori, Andrea Romano, et al.
Neurology|August 27, 2014
Author responseGiovanni Ristori, Silvia Romano, Giulia Coarelli, et al.
Neurology|September 4, 2014
Author responseGiovanni Ristori, Silvia Romano, Giulia Coarelli, et al.
Expert Review of Clinical Immunology|May 6, 2010
Multiple sclerosis etiology: beyond genes and environmentRosella Mechelli, Viviana Annibali, Giovanni Ristori, et al.
Frontiers in Immunology|June 19, 2023
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature reviewGianmarco Bellucci, Angela Albanese, Caterina Rizzi, et al.
Current Medicinal Chemistry|January 26, 2019
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of EdaravoneCristina Agresti, Rosella Mechelli, Stefania Olla, et al.
Pageof 9